Keap1-Nrf2 PPI-IN-2
Keap1-Nrf2 PPI-IN-2 is a Keap1-Nrf2 PPI inhibitor with an EC50 of 14.2 μM. Keap1-Nrf2 PPI-IN-2 covalently binds to Keap1 cysteine residues through its electrophilic itaconate moiety, disrupts the Keap1-Nrf2 protein-protein interaction, releases Nrf2, and promotes its nuclear translocation and antioxidant gene expression, thereby reducing ROS and inhibiting IL-13 production. Keap1-Nrf2 PPI-IN-2 can be used for research on atopic dermatitis.
For research use only. We do not sell to patients.
- Formula: C50H38F10IrN8O3P
- Molecular Weight:1212.06
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
Keap1 0.627 μM (Kd) |
IL-13 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK-293T | IC50 |
8.7 μM
|
Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
42720490 |
| HUVEC | IC50 |
> 10 μM
|
Cytotoxicity against human HUVEC cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Cytotoxicity against human HUVEC cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
42720490 |
| HaCaT | IC50 |
> 10 μM
|
Cytotoxicity against human HaCaT cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Cytotoxicity against human HaCaT cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
42720490 |
| A-375 | IC50 |
9.95 μM
|
Cytotoxicity against human A375 skin cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Cytotoxicity against human A375 skin cancer cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
42720490 |
In Vitro
Keap1-Nrf2 PPI-IN-2 (72 h) exhibits low cytotoxicity in LO2, HUVEC, and HaCaT cell lines, with IC50 values greater than 10 μM, and an IC50 of 8.7 μM in HEK293T cells[1].
Keap1-Nrf2 PPI-IN-2 (20 μM; 0.5 h) binds to Keap1 in HaCaT cell lysates[1].
Keap1-Nrf2 PPI-IN-2 (150 μM; 25 °C) binds to Keap1 with a Kd of 0.627 μM and a stoichiometry of approximately 2:1[1].
Keap1-Nrf2 PPI-IN-2 inhibits the Keap1-Nrf2 PPI with an EC50 of 14.2 μM[1].
Keap1-Nrf2 PPI-IN-2 (10 μM; 2 h) mainly localizes in the cytoplasm of HaCaT cells[1].
Keap1-Nrf2 PPI-IN-2 (10 μM; 1.5-2.5 h) effectively enters HaCaT cells[1].
Keap1-Nrf2 PPI-IN-2 (10 μM) effectively stimulates ARE transcriptional activity in HaCaT cells[1].
Keap1-Nrf2 PPI-IN-2 (72 h) exhibits specific cytotoxic profiles against HaCaT, LO2, HUVEC, and HEK293T cell lines in the MTT assay[1].
Keap1-Nrf2 PPI-IN-2 (10 µM; 8 h) activates ARE-luciferase activity in HaCaT cells[1].
Keap1-Nrf2 PPI-IN-2 (10-20 μM; 2 h) exhibits luminescence in HaCaT and A375 cells after 2 h of treatment[1].
Keap1-Nrf2 PPI-IN-2 (compound 1) (1-10 μM; 8 h) increases ROS levels and the protein levels of NQO1 and HO-1 in HaCaT cells[1].
Keap1-Nrf2 PPI-IN-2 (8 h) modulates ROS levels in HaCaT cells[1].
Keap1-Nrf2 PPI-IN-2 (0-10 μM; 72 h) exhibits moderate cytotoxicity in A375 skin cancer cells with an IC50 of 9.95 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HaCaT
-
Concentration:20 μM
-
Incubation Time:0.5 h
-
Result:Significantly stabilized Keap1 even at high temperatures up to 70 °C.
No significant stabilized effect was observed for Nrf2.
-
Cell Line:HaCaT
-
Concentration:10 μM
-
Incubation Time:2 h
-
Result:Mainly accumulated in the cytoplasm.
-
Cell Line:HaCaT
-
Concentration:1, 3, and 10 μM
-
Incubation Time:8 h
-
Result:Induced NQO1 and HO-1 protein levels in a dose-dependent manner.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (female, 6-8 weeks old, DNFB-induced)[1]
-
Dosage:5; 15 mg/kg
-
Administration:topical; once daily; 12 consecutive days
-
Result:Caused milder body weight loss than dexamethasone.
Showed significantly lower AD lesion severity than the DNFB model group.
Relieved pruritus notably after 4 days.
Markedly reversed DNFB-induced serum IgE elevation.
Ameliorated DNFB-triggered atopic dermatitis lesions.
Restrained inflammatory progression with thinner epidermis and fewer infiltrated mast cells compared with the DNFB model group.
Chemical Information
-
Molecular Weight 1212.06
-
Formula C50H38F10IrN8O3P
-
SMILES
CC1=C(C2=CC=CC=[C-]2[Ir+3]345([N]6=C(N(CCCNC(CC(C(O)=O)=C)=O)C7=C6C=CC=C7)C8=[N]5C=CC=C8)[C-]9=CC=CC=C9C%10=[N]4C(C=C(F)C(F)=C%11)=C%11N=C%10C)[N]3=C(C=C(F)C(F)=C%12)C%12=N1.F[P-](F)(F)(F)(F)F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RT-PCR
Reverse transcription technology uses RNA as a template to synthesize DNA. RT-PCR is simple, specific and sensitive, and can be used to detect gene expression levels and expression differences in cells; detect RNA virus content; clone cDNA sequences of specific genes.
-
Cytoplasmic-Nuclear Fractionated Protein Extraction
Cytoplasmic-nuclear fractionated protein extraction separates soluble cytoplasmic proteins from nuclear-enriched proteins by mild plasma-membrane permeabilization, differential centrifugation, washing of nuclei, and extraction of nuclear proteins for downstream immunoblotting or related molecular analysis. The readout is the relative abundance of a protein in cytoplasmic and nuclear fractions, commonly assessed by western blotting together with compartment markers such as tubulin or pyruvate kinase for cytoplasm and lamin, nucleoporin, hnRNP, H2AX, or Lamin B for nuclear fractions.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Pull-down
The pull-down assay is an in vitro technique used to detect physical interactions between two or more proteins and an invaluable tool for confirming a predicted protein-protein interaction or identifying novel interacting partners. This method typically involves the use of affinity purification with various wash and elution steps.
-
Immunoprecipitation
Immunoprecipitation (IP) is an experimental method that uses the principle of antibody specific binding to purify and enrich target proteins.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
TPA/Croton Oil Ear Edema and Dermatitis
The TPA (12-O-tetradecanoylphorbol-13-acetate) and croton oil-induced mouse ear edema model is a well-established acute cutaneous inflammation system used to evaluate topical anti-inflammatory activity by measuring edema formation, neutrophil infiltration, vascular permeability, and cytokine-mediated skin responses in vivo. The inflammatory response is triggered by topical application of phorbol esters (TPA) or croton oil constituents, leading to rapid activation of protein kinase C signaling, leukocyte recruitment, and increased vascular permeability, which can be quantified by ear thickness, weight, dye extravasation, and biochemical markers such as myeloperoxidase (MPO) activity and pro-inflammatory mediators in ear tissue homogenates. This model is widely used for screening anti-inflammatory agents, where reductions in edema and inflammatory biomarkers reflect suppression of acute dermal inflammation and immune cell infiltration. Histological evaluation typically confirms epidermal
-
Protocol for Bimolecular Fluorescence Complementation (BiFC) Assay
Bimolecular fluorescence complementation detects protein-protein proximity in living or fixed cells by fusing two candidate interaction partners to nonfluorescent N- and C-terminal fragments of a fluorescent protein; when the partners interact or remain close enough, the fluorescent fragments complement, mature, and generate a fluorescent signal at the site of the protein complex. The BiFC readout is fluorescence intensity and subcellular localization of the reconstituted fluorophore, which reflects formation or stabilization of a protein complex rather than direct biochemical binding kinetics; BiFC is therefore useful for mapping where interactions occur in cancer cells, neurons, macrophages, organoid-derived cells, or drug-screening systems, but results should be validated by independent assays such as co-IP or Western blot. BiFC signal formation is delayed by fluorophore maturation and can stabilize otherwise transient complexes, so it is not a real-time reversible interaction assay
-
Real Time qPCR (Q-PCR)
Real-time quantitative PCR (qPCR) quantifies an amplifiable nucleic-acid target by monitoring fluorescence during PCR cycling rather than measuring product only after amplification. The increase in fluorescence tracks accumulation of PCR product, and the quantification cycle (Cq; historically also Ct/CP) is related to the initial amount of target: samples containing more starting target generally reach the defined fluorescence threshold in fewer cycles.
-
Co-Immunoprecipitation
Co-immunoprecipitation technology can verify protein interaction based on the specific immune reaction between antibodies and antigens.
-
Protocol for Yeast Two-Hybrid (Y2H) Assay
The yeast two-hybrid assay detects binary protein-protein interactions by separating a transcription factor into a DNA-binding domain fused to a "bait" protein and a transcriptional activation domain fused to a "prey" protein; if bait and prey interact in yeast, the transcription factor is reconstituted and activates reporter genes such as HIS3, ADE2, lacZ, MEL1, or other selectable/readable reporters. The readout is yeast growth on selective medium and/or reporter activity, which reflects proximity-dependent transcriptional activation in the yeast nucleus rather than direct biochemical binding in the original mammalian, tumor, neuronal, macrophage, or organoid context. Because yeast two-hybrid can generate false positives and false negatives, interaction claims should be validated using independent assays such as co-immunoprecipitation, Western blot, immunofluorescence colocalization, BiFC, pull-down, or mammalian two-hybrid assays.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)